ZHEJIANG KANGLE PHARMACEUTICAL CO.,LTD.

Zhejiang Kangle Pharmaceutical Co., Ltd. was formerly known as Wenzhou Pharmaceutical Factory. It was founded in the 1940s and has a history of more than 70 years. In 2001, it was restructured into Zhejiang Kangle Pharmaceutical Co., Ltd., and in 2007, it underwent standardized joint-stock reform and was renamed Zhejiang Kangle Pharmaceutical Co., Ltd. Currently, the company is headquartered at No. 208 Qujiang Road, Wenzhou Economic and Technological Development Zone, and consists of Wenzhou Binhai Production Base and a production-oriented wholly-owned subsidiary - Lianyungang Kangle Pharmaceutical Co., Ltd. The company has a registered capital of 78.2 million yuan and total assets of 500 million yuan. The company's flagship product, acetaminophen direct-pressure granules, has been exported to the United States and other countries around the world for more than 20 years. After years of hard work, it has been welcomed by high-end markets such as the United States and Europe with its good quality reputation, and its export volume accounts for more than 2/3 of my country's export volume of this product. In 2013, the company built an acetaminophen granule production line with an annual output of 12,000 tons in Wenzhou Binhai Preparation Factory to further expand the market share of this series of products in developed countries such as the United States, Europe, and Japan, and other countries and regions around the world. In recent years, the company's R&D center has successively developed new products such as polygelatin peptide injection and amlodipine besylate tablets, as well as a batch of new varieties of acetaminophen direct-pressure granules that meet foreign trade requirements; the company has also improved some product processes. Improvements include acetaminophen refining mother liquor treatment process and erdosteine ​​one-step new process. The company focuses on scientific research investment and new product development, providing product and technical support for the company's sustainable development, and its development potential continues to increase. In terms of production management, the company strictly follows the requirements of GMP and has built a modern production line that meets the requirements of clean production, forming a complete set of management systems. All types of pharmaceutical production have passed GMP certification. The main export products are acetaminophen, acetyl acetate, etc. Aminophenol direct-pressure granules and erdosteine ​​have been registered in Europe, the United States, Japan, Russia, South Korea and other countries, and have passed on-site certification by the US FDA, South Korea FDA and other agencies, and have passed the European Drug Quality Steering Committee (EDQM) ) presided over the COS certification, obtained the CEP certificate, and obtained the Australian TGA certificate; and passed the ISO14001 environmental management system certification, GB/T28001 occupational health management and safety management certification, and is a member of many world-famous pharmaceutical companies such as Perrigo, Bayer, and Novartis. As a regular supplier to Bristol-Myers Squibb, Johnson & Johnson, etc., we have established a corporate brand among our customer base and established a good reputation.